La covid-19 como una alerta para que el régimen de regulación de los servicios públicos se enfoque en la administración del riesgo y fomente la resiliencia

Main Article Content


Juan Carlos Garay Forero


La propagación de la covid-19, desde su origen en Wuhan, China, una enfermedad de aparente origen zoonótico y las medidas sanitarias empleadas para su contención implicaron un evento con efectos nocivos para la economía y la capacidad productiva de la sociedad que, en un contexto en que es posible que ese tipo de disrupciones sea más frecuente, resaltan la necesidad de que el régimen regulatorio de los servicios públicos se esfuerce en fortalecer y aplicar las lecciones de la administración del riesgo y en incrementar la resiliencia de las empresas reguladas para evitar que el costo de las medidas para la continuidad del servicio sea asumido por los usuarios o los contribuyentes.

Palabras clave:

Article Details


Creative Commons License
Esta obra está bajo licencia internacional Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0.


Acemoglu, D., Chernozhukov, V., Werning, I. y Whinston, M. D. (2020). Optimal targeted lockdowns in a multi-group sir model. nber Working Paper, 27102.

Ahuja, A., Kremer, M. y Zwane, A. P. (2010). Providing safe water: Evidence from randomized evaluations. Annual Review of Resource Economics, 2(1), 237-256.

Amrose, S., Burt, Z. y Ray, I. (2015). Safe drinking water for low-income regions. Annual Review of Environment and Resources, 40, 203-231.

Angelucci, M., Angrisani, M., Bennett, D. M., Kapteyn, A. y Schaner, S. G. (2020). Remote Work and the Heterogeneous Impact of covid-19 on Employment and Health. National Bureau of Economic Research. Working Paper 27749.

Atkeson, A., Kopecky, K. y Zha, T. (2020). Four Stylized Facts about covid-19. National Bureau of Economic Research Working Paper 27719.

Better Regulation Commission (2006). Risk, Responsibility and Regulation – Whose risk is it anyway? Cabinet Office.

Boloș, M. I. y Sabău-Popa, D. C. (2017). Developing an adaptive fuzzy controller for risk management of company cash flow. International Journal of Fuzzy Systems, 19(2), 414-422.

Black, J. (2010). The role of risk in regulatory processes. En R. Baldwin, M. Cave y M. Lodge (eds.), The Oxford handbook of regulation (pp. 302-348). Oxford University Press.

Bloom, D. E., Kuhn, M. y Prettner, K. (2020). Modern infectious diseases: Macroeconomic impacts and policy responses (n.° w27757). National Bureau of Economic Research.

Boni, M. F., Lemey, P., Jiang, X. et al. (2020). Evolutionary origins of the sars-CoV-2 sarbecovirus lineage responsible for the covid-19 pandemic. Nature Microbiology.

Chetty, R., Friedman J. N, Hendren N., Stepner M. y Opportunity Insights Team (2020). The economic impacts of covid-19: Evidence from a new public database built from private sector data.

Chowell, G., Sattenspiel, L., Bansal, S. y Viboud, C. (2016). Mathematical models to characterize early epidemic growth: A review. Physics of Life Reviews, 18, 66-97.

Demsetz, H. (1969). Information and efficiency: another viewpoint. The Journal of Law and Economics, 12(1), 1-22.

Djankov, S. y Evans J. (2020). Firms in financial distress. lse Financial Markets Group Paper Series. Special Paper 260.

Du, R. H., Liang, L. R., Yang, C. Q., Wang, W., Tan-Ze, C., Ming Li, Huan-Zhong, S. (2020). Predictors of mortality for patients with covid-19 pneumonia caused by sars-CoV-2: a prospective cohort study. European Respiratory Journal, 5(5).

Eksin, C., Paarporn, K. y Weitz, J. S. (2019). Systematic biases in disease forecasting–the role of behavior change. Epidemics, 27, 96-105.

Flaxman, S., Mishra, S., Gandy, A., Unwin, H. J. T., Mellan, T. A., Coupland, H. y Monod, M. (2020). Estimating the effects of non-pharmaceutical interventions on covid-19 in Europe. Nature, 584(7820), 257-261.

Friston, K., Costello, A. y Pillay, D. (2020). Dark matter, second waves and epidemiological modelling. medRxiv.

Froot, K. A., Scharfstein, D. S. y Stein, J. C. (1993). Risk management: Coordinating corporate investment and financing policies. The Journal of Finance, 48(5), 1629-1658.

Giddens, A. (1999). Risk and responsibility. Modern Law Review, 62, 1.

Gorbalenya, A. E., Baker, S., Baric, R., de Groot R. J., Drosten, C., Gulyaeva, A., Haagmans, B., Lauber, C., Leontovich, A. M., Neuman, B. W., Penzar, D., Perlman,

S., Poon, LLM ., Damborskiy, D., Sidorov, I., Sola, I., Ziebuhr, J. (2020). The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it sars-CoV-2. Nature Microbiology, 5, 536-544.

Isham, J. y Kähkönen, S. (1999). What determines the effectiveness of community-based water projects. Social capital initiative working paper, 14.

Jonas, O. B. (2013). Pandemic risk. World Bank.

Kihlstrom, R. E. y Laffont, J. J. (1979). A general equilibrium entrepreneurial theory of firm formation based on risk aversion. Journal of Political Economy, 87(4), 719-748.

Knight, F. H. (1921). Risk, uncertainty and profit. Houghton Mifflin.

Kornai, J. (1998). The place of the soft budget constraint syndrome in economic theory. Journal of Comparative Economics, 26(1), 11-17.

Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y. y Xing, X. (2020). Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New England Journal of Medicine, 382, 1199-1207.

Mwangi, P., Otiego, L. y Ndakorerwa, C. (2015). Innovation in scaling up access to water and sanitation services in Kenya. Briefing note to support innovation in scaling up access of water and sanitation services to urban low-income areas. Water and Sanitation Program, World Bank.

Morse, S. S. (2001). Factors in the emergence of infectious diseases. En A. Price-Smith (ed.), Plagues and politics (pp. 8-26). Londres: Palgrave Macmillan.

Morawska, L. y Cao, J. (2020). Airborne transmission of sars-CoV-2: The world should face the reality. Environment International, 139.

National Infraestructure Commission. (2019). Resilience study scoping report. _Resilience_Scoping_Report_September_2019-Final.pdf

Nussbaum, M. (2003). Capabilities as fundamental entitlements: Sen and social justice. Feminist Economics, 9(2-3), 33-59.

OFWAT (2017). Resilience in the Round. Building resilience for the future.

Olivier, C., Gorodnichenko, Y. y Weber, M. (2020). The cost of the covid-19 crisis: lockdowns, macroeconomic expectations, and consumer spending. National Bureau of Economic Research Working Paper 27141.

O’shea, T. J., Cryan, P. M., Cunningham, A. A., Fooks, A. R., Hayman, D. T., Luis, A. D. y Wood, J. L. (2014). Bat flight and zoonotic viruses. Emerging infectious diseases, 20(5), 741.

Patiño-Galindo, J. Á., Filip, I., AlQuraishi, M. y Rabadan, R. (2020). Recombination and lineage-specific mutations led to the emergence of sars-CoV-2. bioRxiv.

Pindyck, R. (2020). Covid-19 and the Welfare Effects of reducing contagion. National Bureau of Economic Research Working Paper 27121.

Ralph, O., Gross, A. y Armstrong, R. (2020). Designing insurance for the next pandemic. Financial Times.

Raz, T., Shenhar, A. J. y Dvir, D. (2002). Risk management, project success, and technological uncertainty. R&D Management, 32(2), 101-109.

Scordis, N. A., Barrese, J. y Wang, P. (2008). The impact of cash flow volatility on systematic risk. Journal of Insurance Issues, 43-71.

Skinner, J. (2009). Where every drop counts: tackling rural Africa’s water crisis. International Institute for Environment and Development (iied): London, uk.

Starr, R., Newfrock, J. y Delurey, M. (2003). Enterprise resilience: managing risk in the networked economy. Strategy and Business, 30, 70-79.

Taylor, L. H., Latham, S. M. y Woolhouse, M. E. (2001). Risk factors for human disease emergence. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, 356(1411), 983-989.

Wolfe, N. D., Dunavan, C. P. y Diamond, J. (2007). Origins of major human infectious diseases. Nature, 447(7142), 279-283.

Wu, Y., Ho, W., Huang, Y., Jin, D. Y., Li, S., Liu, S. L., Liu, X., Qiu, J., Sang, Y., Wang, Q., Yuen, K. Y., Zheng, Z. M. (2020). sars-CoV-2 is an appropriate name for the new coronavirus. A distinct name is needed for the new coronavirus. Lancet, 395, 949-950.

Wu, D., Wu, T., Liu, Q. y Yang, Z. (2020). The sars-CoV-2 outbreak: what we know. International Journal of Infectious Diseases, 44-48.

Zhou, P., Yang, X. L., Wang, X. G., Hu, B., Zhang, L., Zhang, W. y Chen, H. D. (2020). A pneumonia outbreak associated with a new coronavirus of probab


La descarga de datos todavía no está disponible.

Artículos más leídos del mismo autor/a